Skip to main content
. 2019 May 1;36(4):294–301. doi: 10.36141/svdld.v36i4.8418

Table 1.

Demographic and laboratory findings of patients

IPF (n=50) Non-IPF (n=42) p value
Age (Mean±SD) 67.4±7.1 64.9±7.2 0.08
Gender (n) (Female/Male) 12/38 13/29
Non-smoker (n)
Smoker
Ex-smoker
16
10
23
15
6
20
0.76
BMI 27.3±3.9 29±4.1 0.04
6DYT = 6MWT(mt) 342.8±93 362.787.8 0.30
FEV1% 69.6±14.4 77.8±17.7 0.01
FVC % 63±15.2 71.6±15.9 0.01
TLCO % 42.2±15 53.2±20.9 0.006
Clubbing, n 15 3 0.015
Symptom *, n(%)
Dispnea
Coughing
Sputum
46 (92%)
28 (56%)
10 (20%)
33 (78,6%)
21 (50%)
16 (38%)
0,123
0,71
0,09
Comorbidity* (n)
Total (+/-)
Hypertension
Diabetes
Coronary Artery Disease
COPD
Others
32/18
12
16
18
5
2
32/10
16
16
8
5
3
0.51
Radiological findings* (n)
Traction bronchiectasis
Honeycomb
Fibrosis
Glossy opacity
Emphysema
23
41
44
28
13
8
18
35
35
10
0.006
<0.001
0.72
0.005
0.82
Sedimentation 26 (8,100) 26 (4,119) 0.74
CRP 0.6 (0.1 , 25) 0.6 (0.1,13.5) 0.36

*= more than one finding in a patient

Abbrevations: IPF:Idiopatic Pulmonary Fibrosis; BMI: Body mass index; 6MWT: Six minute walk test

SF-36 = Short form-36 Quality of Life; HAM-A = Hamilton Anxiety score; HAM-D = Hamilton Depression score; GAP = Gender Age Physiologic index; 6MWT = 6 Minute walk Test